Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Indoco Remedies Limited ( (IN:INDOCO) ) has shared an announcement.
Indoco Remedies Limited announced that the Goods and Service Tax (GST) Authority has dropped proceedings against the company regarding a Show Cause Notice (SCN) related to issues like excess claim of Input Tax Credit (ITC) and GSTR9C reconciliation. The resolution of this matter indicates no financial or operational impact on the company, which is a positive development for its stakeholders and market positioning.
More about Indoco Remedies Limited
Indoco Remedies Limited operates in the pharmaceutical industry, providing a range of products including formulations and active pharmaceutical ingredients. The company focuses on both domestic and international markets, catering to various therapeutic segments.
YTD Price Performance: -29.78%
Average Trading Volume: 7,050
Current Market Cap: 21.5B INR
Learn more about INDOCO stock on TipRanks’ Stock Analysis page.